CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-05-18 | COX GEOFFREY F Non-executive Chairman | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2007-05-18 | LYNCH TIMOTHY P Director | Grant or award | +3,846 | $5.20 | $20K | 3,846 |
| 2007-05-18 | LYNCH TIMOTHY P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | JENCKES LINDA Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | HARVEY RICHARD A JR Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Grant or award | +30,000 | 126,730.42 | ||
| 2007-05-18 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2007-05-18 | DAVIS PETER B Director | Grant or award | +3,846 | 7,814 | ||
| 2007-05-18 | DAVIS PETER B Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | CASTALDI DAVID L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-10 | Third Point LLC | Purchase | +135,000 | $5.25 | $709K | 6,690,000 |
| 2007-05-10 | Third Point LLC | Purchase | +200,000 | $5.25 | $1.1M | 6,890,000 |
| 2007-05-09 | Third Point LLC | Purchase | +225,000 | $5.25 | $1.2M | 6,555,000 |
| 2007-05-08 | Third Point LLC | Purchase | +350,000 | $5.15 | $1.8M | 6,100,000 |
| 2007-05-08 | Third Point LLC | Purchase | +230,000 | $5.13 | $1.2M | 6,330,000 |
| 2007-02-15 | Hudson Leslie Interim President & CEO | Grant or award | +4,355 | 4,355 | ||
| 2007-02-15 | Hudson Leslie Interim President & CEO | Grant or award | +8,711 | 13,066 | ||
| 2006-11-10 | LYNCH TIMOTHY P Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2006-11-10 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 |
Page 39 of 42 · 830 trades